Beyond the augmentation of the capacity to efflux various therapeutic cytotoxic drugs, the ABC dysregulated genes are being increasingly associated with cancer development and evolution processes (angiogenesis, apoptosis, proliferation, invasion, metastasis, etc.)[50]. This evidence concerns the gene ABCB6 and cancer.